Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
06/2000
06/29/2000CA2355137A1 Non-peptide nk1 receptors antagonists
06/29/2000CA2355074A1 Lymphocytic membrane proteins
06/29/2000CA2354511A1 Il-5 inhibiting 6-azauracil derivatives
06/29/2000CA2353960A1 Improvement of tolerance to a xenograft
06/29/2000CA2353848A1 Large molecule drug delivery system using aerosolized membrane-mimetic amphiphiles
06/29/2000CA2352309A1 Oral vaccine against diarrhea
06/28/2000EP1013764A1 Immunomodulators
06/28/2000EP1013660A1 2-fluorofucosyl-n-aroylglucosamine derivatives, intermediates therefor, and processes for producing these
06/28/2000EP1013639A1 Aryl carboxylic acid and tetrazole derivatives comprising a carbamoyloxy unit
06/28/2000EP1013283A2 Pharmaceutical and foodstuff compositions containing transferrins and antibacteral agents for potentiating host defence activity and the treatment of infections
06/28/2000EP1013282A2 Pharmaceutical and foodstuff compositions containing transferrins and antibacteral agents for potentiating host defence activity and the treatment of infections
06/28/2000EP1013276A1 Aminoazacycloalkanes as CCR5 modulators
06/28/2000EP1012320A2 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses
06/28/2000EP1012309A2 Chimeric polypeptides containing chemokine domains
06/28/2000EP1012308A1 Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors
06/28/2000EP1012305A1 Component of bromelain
06/28/2000EP1012304A1 Component of bromelain
06/28/2000EP1012302A1 Human nucleotide pyrophosphohydrolase
06/28/2000EP1012281A2 Human leukocyte calcium activated potassium channel polypeptide
06/28/2000EP1012273A2 Secreted proteins and polynucleotides encoding them
06/28/2000EP1012270A2 Kay - a novel immune system protein
06/28/2000EP1012267A2 An antisense oligonucleotide preparation method
06/28/2000EP1012266A1 Galectin 8, 9, 10 and 10sv
06/28/2000EP1012261A1 Secreted proteins and polynucleotides encoding them
06/28/2000EP1012242A1 Human sigma receptor
06/28/2000EP1012187A2 Chemokine peptides, variants, derivatives and analogs. their use in methods to inhibit or augment an inflammatory response
06/28/2000EP1011725A1 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF
06/28/2000EP1011719A1 Synthetic antigens for cd1-restricted immune responses
06/28/2000EP1011718A1 Anti-viral treatment with pertussis toxin b oligomer
06/28/2000EP1011709A1 Inhibition of apoptotis using prosaposin receptor agonists
06/28/2000EP1011686A1 Modulation of human mast cell activation
06/28/2000EP1011663A1 BETA-LACTAM INHIBITORS OF CoA-IT
06/28/2000EP1011637A1 Modulation of drug loading in multivesicular liposomes
06/28/2000EP0754057B1 Compositions and methods for vaccines comprising alpha-galactosyl epitopes
06/28/2000EP0706394A4 Method and composition for topical treatment of damaged tissue using histamine phosphate as active ingredient
06/28/2000EP0557418B1 A beta-type transforming growth factor
06/28/2000CN1258301A Antiviral protease inhibitors
06/28/2000CN1258296A Pyridine derivatives and pharmaceutical compositions contg. them
06/28/2000CN1258293A Substd. 2-(2,6-dioxopiperidin-3-yl)-phthalimides and 1-oxoisoindolines and method of reducing TNF 'alpha' levels
06/28/2000CN1258219A Benzocycloheptathiophene compounds
06/28/2000CN1257872A Leptospiral vaccine antigen for preventing leptospirosis
06/28/2000CN1053924C Process for preparing CR1 and thrombolytic agent contg. composition
06/27/2000US6080878 Method of preparing 16-dehydro vitamin D compounds
06/27/2000US6080790 Selective and potent inhibitors of phosphodiesterase iv and are useful for the prophylaxis and treatment of inflammatory diseases and the alleviation of conditions associated with central nervous malfunction
06/27/2000US6080764 Superoxide radical inhibitor
06/27/2000US6080742 Substituted benzamides
06/27/2000US6080717 Treatment of individual having a need to inhibit a polypeptide, comprising administering a bactericidal antagonist of the polypeptide
06/27/2000US6080409 Immunostimulatory method
06/27/2000US6080406 Hematopoietic cytokine receptor
06/27/2000CA2134083C Prophylactic and therapeutic agents for autoimmune diseases
06/27/2000CA2013960C Substituted dibenzofurans and methods of using same
06/22/2000WO2000036421A1 Use of vascular endothelial growth factor (vegf)
06/22/2000WO2000036113A2 Extending graft survival by heme oxygenase-i expression induced immunomodulation
06/22/2000WO2000036107A2 Compositions and methods for therapy and diagnosis of ovarian cancer
06/22/2000WO2000036105A1 Prostacyclin-stimulating factor-2
06/22/2000WO2000036103A1 Cytokine receptor chain
06/22/2000WO2000036092A2 METHOD FOR THE HIGH LEVEL EXPRESSION OF ACTIVE LYMPHOTOXIN-β RECEPTOR IMMUNOGLOBULIN CHIMERIC PROTEINS AND THEIR PURIFICATION
06/22/2000WO2000036089A2 Methods of immunosuppression
06/22/2000WO2000035939A2 Connective tissue growth factor fragments and methods and uses thereof
06/22/2000WO2000035937A1 47 human secreted proteins
06/22/2000WO2000035936A1 Connective tissue growth factor fragments and methods and uses thereof
06/22/2000WO2000035915A1 Piperazine derivatives
06/22/2000WO2000035885A1 Cyclic hydrazine derivatives as tnf-alpha inhibitors
06/22/2000WO2000035867A1 Novel ligands of nuclear receptor
06/22/2000WO2000035484A2 Methods and compositions for decreasing allergic reactions to surface allergens
06/22/2000WO2000035482A2 Novel adjuvant for subunit or component vaccines
06/22/2000WO2000035476A1 In ovo vaccination of 1 type marek's disease virus
06/22/2000WO2000035472A2 Cytokine combination therapy
06/22/2000WO2000035442A1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists
06/22/2000WO2000035435A1 Use of a mek inhibitor for preventing transplant rejection
06/22/2000WO2000035428A2 Tricyclic nitrogen heterocycles as pde iv inhibitors
06/22/2000WO2000035280A1 Exo-r-mecamylamine formulation and use in treatment
06/22/2000WO2000035279A1 Exo-s-mecamylamine formulation and use in treatment
06/22/2000WO2000012703A3 Protein transport-associated molecules
06/22/2000WO2000012138A3 Cells expressing immunoregulatory molecules and uses therefor
06/22/2000WO2000010599A3 IMMUNOGENIC β-PROPIONAMIDO-LINKED POLYSACCHARIDE PROTEIN CONJUGATE USEFUL AS A VACCINE PRODUCED USING AN N-ACRYLOYLATED POLYSACCHARIDE
06/22/2000WO1999059615A9 Hybrid polypeptides with enhanced pharmacokinetic properties
06/22/2000CA2718376A1 Novel adjuvant for subunit or component vaccines
06/22/2000CA2393442A1 Exo-r-mecamylamine formulation and use in treatment
06/22/2000CA2362423A1 47 human secreted proteins
06/22/2000CA2355890A1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists
06/22/2000CA2355650A1 Methods and compositions for decreasing allergic reactions to surface allergens
06/22/2000CA2355363A1 Prostacyclin-stimulating factor-2
06/22/2000CA2355299A1 Novel ligands of nuclear receptor
06/22/2000CA2355066A1 Extending graft survival by heme oxygenase-i expression induced immunomodulation
06/22/2000CA2354875A1 Piperazine derivatives
06/22/2000CA2354539A1 A method for the high level expression of active lymphotoxin-.beta. receptor immunoglobulin chimeric proteins and their purification
06/22/2000CA2354456A1 Connective tissue growth factor fragments and methods and uses thereof
06/22/2000CA2354422A1 Connective tissue growth factor fragments and methods and uses thereof
06/22/2000CA2354156A1 Compositions and methods for therapy and diagnosis of ovarian cancer
06/22/2000CA2354147A1 Methods of immunosuppression
06/22/2000CA2353924A1 Cyclic hydrazine derivatives as tnf-alpha inhibitors
06/22/2000CA2346684A1 Use of a mek inhibitor for preventing transplant rejection
06/22/2000CA2345752A1 Tricyclic nitrogen heterocycles as pde iv inhibitors
06/22/2000CA2320414A1 In ovo vaccination of type 1 marek's disease virus
06/22/2000CA2290219A1 Leptospira vaccine antigens for the prevention of leptospirosis
06/22/2000CA2289422A1 Process and intermediates for preparing 5-lipoxygenase inhibitors
06/21/2000EP1009831A2 Agonist antibodies to the thrombopoietin receptor, and their therapeutic uses
06/21/2000EP1009824A1 COMPOSITIONS AND METHODS FOR MODULATING CELLULAR NF-kappaB ACTIVATION
06/21/2000EP1009821A1 Membrane-bound cytokine compositions and methods of modulating an immune response using same
1 ... 933 934 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 ... 1172